We are live on ! Find out more
RC

RegentAtlantic Capital Portfolio holdings

AUM $3.34B
1-Year Est. Return 14.54%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
AUM
$1.48B
AUM Growth
+$48.8M
Cap. Flow
+$12.3M
Cap. Flow %
0.83%
Top 10 Hldgs %
26.29%
Holding
455
New
22
Increased
138
Reduced
231
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 17.63%
2 Healthcare 12.79%
3 Financials 12.07%
4 Industrials 8.57%
5 Communication Services 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
1
iShares Core MSCI Emerging Markets ETF
IEMG
$153B
$117M 7.89%
2,276,556
+108,722
+5% +$5.56M
MLPX icon
2
Global X MLP & Energy Infrastructure ETF
MLPX
$3.67B
$51M 3.44%
1,313,831
+46,761
+4% +$1.82M
AAPL icon
3
Apple
AAPL
$4.79T
$40.9M 2.76%
827,136
+15,408
+2% +$751K
MSFT icon
4
Microsoft
MSFT
$2.9T
$34.6M 2.33%
258,014
+2,374
+0.9% +$301K
FNDA icon
5
Schwab Fundamental US Small Company Index ETF
FNDA
$9.22B
$29.8M 2.01%
1,582,578
+35,730
+2% +$671K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.06T
$24.2M 1.63%
113,740
-7,393
-6% -$1.53M
JNJ icon
7
Johnson & Johnson
JNJ
$615B
$23.9M 1.61%
171,674
-7,030
-4% -$973K
CMCSA icon
8
Comcast
CMCSA
$84B
$23.5M 1.58%
556,405
-5,106
-0.9% -$215K
INTC icon
9
Intel
INTC
$516B
$22.6M 1.52%
472,336
+877
+0.2% +$43.5K
EXC icon
10
Exelon
EXC
$47.8B
$22.6M 1.52%
660,474
+21,773
+3% +$768K
PXF icon
11
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.86B
$21.4M 1.44%
526,914
-13,237
-2% -$539K
PFE icon
12
Pfizer
PFE
$141B
$21.3M 1.44%
519,277
-10,595
-2% -$421K
META icon
13
Meta Platforms (Facebook)
META
$1.59T
$18.6M 1.25%
96,313
+1,334
+1% +$244K
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.17T
$18.3M 1.24%
338,860
+42,460
+14% +$2.46M
DIS icon
15
Walt Disney
DIS
$166B
$18.3M 1.23%
131,150
-14,338
-10% -$1.9M
ELV icon
16
Elevance Health
ELV
$84.4B
$17.4M 1.18%
61,811
-25
-0% -$6.83K
VNQI icon
17
Vanguard Global ex-US Real Estate ETF
VNQI
$3.47B
$16.3M 1.1%
276,579
-1,296
-0.5% -$75.9K
NOC icon
18
Northrop Grumman
NOC
$74.6B
$15.7M 1.06%
48,576
-187
-0.4% -$55.7K
TMO icon
19
Thermo Fisher Scientific
TMO
$196B
$14.7M 0.99%
50,217
-1,186
-2% -$327K
UNH icon
20
UnitedHealth
UNH
$392B
$14.5M 0.98%
59,419
-414
-0.7% -$99.6K
BAC icon
21
Bank of America
BAC
$432B
$13.6M 0.91%
468,302
-443
-0.1% -$12.8K
FNDX icon
22
Schwab Fundamental US Large Company Index ETF
FNDX
$26.5B
$13.2M 0.89%
1,015,044
-2,376
-0.2% -$30.4K
T icon
23
AT&T
T
$160B
$12.8M 0.86%
507,153
+26,264
+5% +$630K
ORCL icon
24
Oracle
ORCL
$362B
$12.5M 0.84%
218,804
+32,656
+18% +$1.77M
IBM icon
25
IBM
IBM
$193B
$12.4M 0.83%
93,844
+12,861
+16% +$1.69M

Similar funds

RegentAtlantic Capital's Q2 2019 Portfolio in Review

As of Q2 2019, RegentAtlantic Capital held 455 positions worth $1.48B, up 3.4% from $1.44B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

RegentAtlantic Capital's Q2 2019 filing shows 22 new, 138 increased, 231 reduced and 21 closed positions. Its largest new stake was Dow Inc: 35,576 shares worth $1.75M. The largest sale was DuPont de Nemours, an estimated $2.52M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • RegentAtlantic Capital's largest Q2 2019 buy was Dow Inc: 35,576 shares worth $1.75M.
  • RegentAtlantic Capital added most to iShares Core MSCI Emerging Markets ETF in Q2 2019, an estimated $5.56M increase.
  • RegentAtlantic Capital's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $2.52M.
  • RegentAtlantic Capital fully exited Syneos Health, Inc. Class A Common Stock in Q2 2019, selling an estimated $1.35M.
  • RegentAtlantic Capital's ten largest holdings make up 26% of its $1.48B portfolio in Q2 2019.
  • RegentAtlantic Capital opened 22 new positions and closed 21 in Q2 2019.
  • RegentAtlantic Capital's portfolio value rose 3.4% quarter-over-quarter to $1.48B.

Based on RegentAtlantic Capital's 13F filing for Q2 2019, filed 23 Jul 2019.